Ticker
CSCIFCompany Name
COSCIENS BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Gross Profit | Gross Profits to Assets |
---|---|---|---|
6/30/2025 | $ 27.56M | $ 4.42M | 16.05% |
3/31/2025 | $ 31.14M | $ 4.27M | 13.71% |
12/31/2024 | $ 35.07M | $ 4.73M | 13.48% |
9/30/2024 | $ 43.77M | $ 1.83M | 4.18% |
6/30/2024 | $ 50.05M | $ 865K | 1.73% |
3/31/2024 | $ 31.79M | $ 2.15M | 6.77% |
12/31/2023 | $ 37.02M | $ 4.28M | 11.55% |
9/30/2023 | $ 42.49M | $ 6.64M | 15.64% |
6/30/2023 | $ 46.48M | $ 8.5M | 18.28% |
3/31/2023 | $ 51.28M | $ 6.16M | 12% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Assets
(=) GPA
GPA for COSCIENS BIOPHARMA INC is calculated as follows: GP [ $ 88K ] / Assets [ $ 32.27M ]
(=) GPA [ 0.27% ]
Minimum
Sep 30, 2020
Maximum
Jun 30, 2023
Average
Median
filtered constituents | 4.13K |
---|---|
min | -50.32% |
max | 83.98% |
average | 20.16% |
median | 15.35% |
std | 19.94% |